Our active clinical studies explore innovative therapies aimed at improving outcomes, expanding treatment options, and advancing the future of patient car
Adults with moderate to severe Crohn’s disease confirmed by symptoms and endoscopic findings.
Adults diagnosed with ulcerative colitis.
Adults with a confirmed diagnosis of advanced or metastatic cancer.
Adults with relapsed or refractory multiple myeloma whose disease has returned or no longer responds to previous treatment. This Phase 3 clinical study is evaluating the investigational therapy inobrodib in combination with pomalidomide and dexamethasone compared with standard available treatment to assess its safety and effectiveness in treating multiple myeloma.
Adults with a recent cancer diagnosis (within the past 90 days). This study is evaluating investigational blood-based testing methods for early cancer detection and monitoring.
We are actively working on initiating additional clinical trials across multiple therapeutic areas. If you are interested in participating or would like more information, please contact our site directly.
Participation in clinical research is voluntary. Some studies may offer compensation for time and travel. Compensation, if provided, varies by study and is discussed during the informed consent process. Additional eligibility criteria apply, and final eligibility is determined by the study team following screening.
Copyright © 2026 Regis Clinical Research - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.